What Congress has guaranteed, the courts have taken away -
The Supreme Court is about to receive a Petition for Certiorari in a case that impacts how long a patent protects new inventions, we expect. Specifically, the case...more
5/16/2024
/ Food and Drug Administration (FDA) ,
Hatch-Waxman ,
Inventions ,
Obviousness-Type Double Patenting (ODP) ,
Patent Term Adjustment ,
Patent Trial and Appeal Board ,
Patents ,
Petition for Writ of Certiorari ,
Popular ,
SCOTUS ,
USPTO
The Supreme Court is expected to consider Teva’s pending petition for certiorari in the highly anticipated GlaxoSmithKline LLC v. Teva Pharms. USA, Inc. on May 11, 2023, a case that could carry enormous implications for the...more
5/12/2023
/ Abbreviated New Drug Application (ANDA) ,
Copyright Infringement ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Hatch-Waxman ,
Healthcare ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Labeling ,
Patent Litigation ,
Petition for Writ of Certiorari ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
SCOTUS ,
Teva Pharmaceuticals